Article

Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma

2020-11-19

Abstract excerpt

<h4>Background: </h4> Renal cell carcinoma (RCC) is the most common malignancy in urinary system. Despite substantial improvements in available treatments, survival outcome of advanced RCC is unsatisfied. Identifying novel biomarker to assist early diagnosis and screen immunotherapy sensitive patients would be beneficial. CD248 is a promising candidate that deserves to be investigated. <h4>Methods: </h4>: The Canc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 60f88012-ad94-5b58-b9bc-cbd85a031175
DOI: 10.21203/rs.3.rs-108745/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell CarcinomaDOI 10.21203/rs.3.rs-108745/v1Read

A molecular subtype model of ccRCC based on immune-related genes for predicting immunotherapy responseSemantic proximity Read

Identification of Potential Biomarkers Associated With Immune Infiltration in Papillary Renal Cell CarcinomaSemantic proximity Read

ISPRF: A Machine Learning Model to Predict the Immune Subtype of Kidney Cancer Samples by Four GenesSemantic proximity Read

A promising prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genesSemantic proximity Read

Renal Cell Carcinoma: A Comprehensive in Silico Study in Searching for Therapeutic TargetsSemantic proximity Read

Prognostic Risk Model for Advanced Renal Cell Carcinoma (RCC) with Immune-Related GenesSemantic proximity Read

Molecular Signature Of Subtypes Of Renal Cell Carcinomas And Immunotherapy StrategySemantic proximity Read

Immunophenotyping analysis of renal cell carcinoma identified APOC1 as an immune-related biomarker and therapeutic targetSemantic proximity Read

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read

From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaSemantic proximity Read

Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma.Semantic proximity Read

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesSemantic proximity Read